February 28, 2015 12:57 PM ET


Company Overview of MyoKardia, Inc.

Executive Profile

Leslie Leinwand

Co-Founder, MyoKardia, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships


Dr. Leslie Leinwand co-founded MyoKardia, Inc. in 2012. Dr. Leinwand serves as Director of the Colorado Initiative in Molecular Biotechnology at University of Colorado. She is a Molecular, Cellular, and Developmental Biology (MCDB) Professor at University of Colorado. She has been at the University of Colorado since 1995. She was recruited here to be Chair of MCDB. She joined the faculty at Albert Einstein College of Medicine in New York in 1981 and remained there until ...

Corporate Headquarters

400 East Jamie Court
South San Francisco, California 94080

United States

Phone: 650-741-0900
Fax: --

Board Members Memberships



Bachelor's Degree
Cornell University
Yale University
Post-Doctoral Training
Rockefeller University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MyoKardia, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.